&Partners’s Boston Scientific BSX Stock Holding History

&Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.3M	Sell	69,266 -15,680	-18%	-$1.25M	0.02%	574
2025 Q4	$8.1M	Buy	84,946 +9,354	+12%	+$917K	0.04%	361
2025 Q3	$7.37M	Buy	75,592 +17,387	+30%	+$1.8M	0.05%	330
2025 Q2	$6.43M	Buy	58,205 +2,189	+4%	+$221K	0.05%	317
2025 Q1	$5.55M	Buy	56,016 +4,977	+10%	+$501K	0.06%	278
2024 Q4	$4.63M	Buy	51,039 +14,771	+41%	+$1.3M	0.06%	292
2024 Q3	$3.04M	Buy	36,268 +26,456	+270%	+$2.09M	0.06%	284
2024 Q2	$756K	Buy	9,812 +4,796	+96%	+$351K	0.03%	412
2024 Q1	$344K	Buy	+5,016	New	+$323K	0.05%	338

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

&Partners's BSX Position: Q1 2026 in Review

&Partners reduced its Boston Scientific (BSX) stake by 18% in Q1 2026, selling an estimated $1.25M and leaving 69,266 shares worth $4.3M. The position accounts for 0.02% of the portfolio, ranked #574.

&Partners first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.1M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

&Partners held 69,266 shares of Boston Scientific worth $4.3M as of Q1 2026.
&Partners sold 15,680 Boston Scientific shares in Q1 2026, an estimated $1.25M.
Boston Scientific made up 0.02% of &Partners's portfolio in Q1 2026, its #574 holding.
&Partners first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
&Partners's Boston Scientific position peaked at $8.1M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.